These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4115915)

  • 1. Effect of halofenate on binding of various drugs to human plasma proteins and on the plasma half-life of antipyrine in monkeys.
    Hucker HB; Stauffer SC; White SE
    J Pharm Sci; 1972 Sep; 61(9):1490-2. PubMed ID: 4115915
    [No Abstract]   [Full Text] [Related]  

  • 2. Anomalous results of studies on drug interaction in man. II. Halofenate (mk-185) and antipyrine, bishydroxycoumarin, and warfarin.
    Vesell ES; Passananti GT
    Pharmacology; 1975; 13(2):112-27. PubMed ID: 49900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 2-acetoamidoethyl (p-chlorophenyl) (m-trifluoromethylphenoxy) acetate (halofenate) on cholesterol oxidation by rat liver mitochondria.
    Kritchevsky D; Tepper SA
    Proc Soc Exp Biol Med; 1972 Apr; 139(4):1284-7. PubMed ID: 5023326
    [No Abstract]   [Full Text] [Related]  

  • 4. A pharmacokinetic approach to the understanding of therapeutic effects and side effects of salicylates.
    Brune K; Graf P; Rainsford KD
    Agents Actions Suppl; 1977; (1):9-26. PubMed ID: 272828
    [No Abstract]   [Full Text] [Related]  

  • 5. Microbodies in experimentally altered cells. VI. Thyroxine displacement from plasma proteins and clofibrate effect.
    Azarnoff DL; Svoboda DJ
    Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):386-93. PubMed ID: 4397540
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of drugs in rabbits with experimental acute renal failure.
    Van Peer A; Belpaire F; Bogaert M
    Pharmacology; 1978; 17(6):307-14. PubMed ID: 733890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction between cholestyramine and drugs.
    Gallo DG; Bailey KR; Sheffner AL
    Proc Soc Exp Biol Med; 1965 Oct; 120(1):60-5. PubMed ID: 5852732
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of oral high-dose progestins on the disposition of antipyrine, digitoxin, and warfarin in patients with advanced breast cancer.
    Lundgren S; Kvinnsland S; Utaaker E; Bakke O; Ueland PM
    Cancer Chemother Pharmacol; 1986; 18(3):270-5. PubMed ID: 2948732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of MK-185 on thyroid function.
    Ryan JR; Jain A; Maha GE; McMahon FG
    Clin Pharmacol Ther; 1971; 12(3):464-7. PubMed ID: 4105444
    [No Abstract]   [Full Text] [Related]  

  • 10. High speed liquid chromatography, 14C-radioassay and spectrophotometry for measuring antipyrine plasma half-life in rhesus monkeys (Macaca mulatta).
    Clark CR; Krieger RI; Miller JL
    Pharmacology; 1978; 17(2):98-103. PubMed ID: 98774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interactions of salicylates and other nonsteroid anti-inflammatory agents].
    Royer RJ; Tamisier JN; Netter P; Faure G; Gaucher A
    Sem Hop; 1977 Nov; 53(38):2121-4. PubMed ID: 204021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The uricosuric action of halofenate (MK-185) in patients with hyperuricemia or uncomplicated primary gout and hyperlipidemia.
    Hutchison JC; Wilkinson WH
    Atherosclerosis; 1973; 18(3):353-62. PubMed ID: 4584481
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal excretion and uricosuric properties of halofenate, a hypolipidemic-uricosuric agent, in the chimpanzee.
    Fanelli GM; Bohn DL; Reilly SS; Baer JE
    J Pharmacol Exp Ther; 1972 Feb; 180(2):377-96. PubMed ID: 5010680
    [No Abstract]   [Full Text] [Related]  

  • 14. [Conditions for the occurrence of drug interactions during biotransformation].
    Grille W; Johnsen K; Kolenda KD
    Med Klin; 1979 Jan; 74(3):55-67. PubMed ID: 83532
    [No Abstract]   [Full Text] [Related]  

  • 15. Monitoring of plasma levels of a hypolipemic agent.
    Baer JE
    Clin Pharmacol Ther; 1974 Jul; 16(1):272-3. PubMed ID: 4843317
    [No Abstract]   [Full Text] [Related]  

  • 16. Antipyrine plasma half-life. In vivo indicator of oxidative metabolic capability in Rhesus monkeys (Macaca mulatta).
    Miller JL; Clark CR; Gee SJ; Krieger RI
    Pharmacology; 1978; 16(5):279-86. PubMed ID: 417345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug displacement from protein-binding and redistributional interactions.
    McQueen EG
    Prog Biochem Pharmacol; 1974; 9():122-8. PubMed ID: 4140531
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of age and sex on human drug metabolism.
    O'Malley K; Crooks J; Duke E; Stevenson IH
    Br Med J; 1971 Sep; 3(5775):607-9. PubMed ID: 5569980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunologic approach to the understanding of the physiologic disposition.
    Weiner M
    Life Sci; 1973 Dec; 13(11):1473-81. PubMed ID: 4129292
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of aminoglutethimide on antipyrine, theophylline, and digitoxin disposition in breast cancer.
    Lønning E; Kvinnsland S; Bakke OM
    Clin Pharmacol Ther; 1984 Dec; 36(6):796-802. PubMed ID: 6499359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.